<http://ns.inria.fr/covid19/1ca5b7ce367a0063043dc4166e74a57c01567525#body_text>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://ns.inria.fr/covid19/DocumentBody> .
<http://ns.inria.fr/covid19/1ca5b7ce367a0063043dc4166e74a57c01567525#body_text>	<http://purl.org/dc/terms/subject>	"Antirheumatic products" .
<http://ns.inria.fr/covid19/1ca5b7ce367a0063043dc4166e74a57c01567525#body_text>	<http://purl.org/vocab/frbr/core#partOf>	<http://ns.inria.fr/covid19/1ca5b7ce367a0063043dc4166e74a57c01567525> .
<http://ns.inria.fr/covid19/1ca5b7ce367a0063043dc4166e74a57c01567525#body_text>	<http://purl.org/dc/terms/subject>	"Physical chemistry" .
<http://ns.inria.fr/covid19/1ca5b7ce367a0063043dc4166e74a57c01567525#body_text>	<http://purl.org/dc/terms/subject>	"Glycosaminoglycans" .